persephone: 6 vs. 12-month adjuvant trastuzumab in early breast cancer
Published 6 years ago • 362 plays • Length 1:56Download video MP4
Download video MP3
Similar videos
-
4:04
the persephone trial: 6 months and 12 months of trastuzumab in breast cancer
-
6:42
6 months trastuzumab non-inferior to 12 months for her2 positive early breast cancer
-
4:29
pertuzumab, trastuzumab and cyclophosphamide in older patients with her2 breast cancer
-
2:52
5-year correlative analysis of atempt: adjuvant t-dm1 vs paclitaxel trastuzumab for stage i her2 bc
-
1:56
optimizing adjuvant treatment in hr /her2- early breast cancer
-
10:33
12 things i wish i knew before starting chemo | chemo tips; my 2nd cancer journey
-
4:11
what is her2 positive breast cancer? | treatment/therapies for her2 positive breast cancer
-
9:19
#trastuzumab | uses, dosage, side effects and mechanism | herceptin
-
0:53
eleanor: real-world study of extended adjuvant neratinib in her2 /hr early breast cancer
-
4:16
adjuvant treatment for stage i her2 breast cancer
-
5:46
adjuvant trastuzumab emtansine vs paclitaxel and trastuzumab for her2-positive breast cancer
-
3:46
aphinity: 6-year follow-up results of dual her2 blockade in her2 breast cancer
-
2:22
cdk4/6 inhibitors in early stage hr /her2- disease
-
4:12
optimizing treatment in patients with early-stage her2-positive breast cancer
-
10:05
piii trial supports current standard 12-month adjuvant trastuzumab for her2-positive breast cancer
-
2:15
treatment strategies for her2 metastatic breast cancer
-
1:46
dr. esteva discusses adjuvant trastuzumab in her2 breast cancer
-
1:17
correlation between trop2 and pcr in patients with her2-positive early breast cancer
-
1:56
apt: adjuvant paclitaxel and trastuzumab for node-negative, her2 breast cancer
-
1:30
neelima denduluri, md, offers opinion on the persephone trial in early her2 breast cancer
-
8:31
#esmo21 expert video report on her2-positive early breast cancer
-
1:59
adapt: de-escalated neoadjuvant pertuzumab trastuzumab with or without paclitaxel in hr-/her2 ebc